Patients and their families in Karachi are currently struggling to access essential medicines, including advanced cancer treatments, vaccines, and other critical drugs, according to doctors, pharmaceutical industry representatives, and medicine traders.
Healthcare professionals warn that the shortage is affecting both routine and urgent treatments, leaving patients with limited options at retail pharmacies. Many critical medications are either unavailable or in short supply, creating significant challenges for those in need of timely medical care.
Industry sources clarify that the shortage is not linked to ongoing regional conflicts. Most imported medicines and pharmaceutical raw materials in Pakistan come from China, which continues normal commercial operations, ensuring supply chains remain intact.
Experts attribute the disruption primarily to delays in the official notification of prices for certain medications. Until new price lists are approved and communicated, pharmacies face restrictions on selling these drugs, which directly impacts patient access.
The shortage highlights structural challenges in Pakistan’s pharmaceutical supply chain and pricing mechanisms. Healthcare professionals emphasize the need for timely regulatory approvals to prevent interruptions in the availability of life-saving treatments.
Patients requiring critical care, particularly those undergoing cancer therapy or needing vaccines, are most affected. Doctors urge the government and relevant authorities to expedite the approval and notification process to ensure essential medicines are available across the city.
Industry representatives also stress that prompt resolution is crucial to avoid further strain on Karachi’s healthcare system, which is already under pressure due to population density and high patient demand.
Authorities are expected to address the issue in the coming weeks, with the hope that proper regulatory measures and price notifications will restore consistent access to these vital medications.
